Cargando…
A Novel PEGylation Method for Improving the Pharmacokinetic Properties of Anti-Interleukin-17A RNA Aptamers
The obstacles to the development of therapeutic aptamers for systemic inflammatory diseases, such as nuclease degradation and renal clearance, have not been fully overcome. Here, we report a novel PEGylation method, sbC-PEGylation, which improves the pharmacokinetic properties of RNA aptamers that a...
Autores principales: | Haruta, Kazuhiko, Otaki, Natsuki, Nagamine, Masakazu, Kayo, Tomoyoshi, Sasaki, Asako, Hiramoto, Shinsuke, Takahashi, Masayuki, Hota, Kuniyoshi, Sato, Hideaki, Yamazaki, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312557/ https://www.ncbi.nlm.nih.gov/pubmed/27827561 http://dx.doi.org/10.1089/nat.2016.0627 |
Ejemplares similares
-
In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library
por: Wang, Hanlu, et al.
Publicado: (2017) -
Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma
por: Tang, Jiaze, et al.
Publicado: (2017) -
Interleukin-10: An Anti-Inflammatory
Marker To Target
Atherosclerotic Lesions via PEGylated Liposomes
por: Almer, Gunter, et al.
Publicado: (2012) -
Selection and characterization of single-stranded DNA aptamers against interleukin-5
por: Jamalvandi, Mina, et al.
Publicado: (2019) -
Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
por: Ganson, Nancy J., et al.
Publicado: (2015)